Global Veterinary Vaccine

Veterinary Vaccine Comprehensive Study by Type (Livestock Vaccines {Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Others}, Companion Animal Vaccines {Canine Vaccines, Feline Vaccines, Equine Vaccines}), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Others) Players and Region - Global Market Outlook to 2027

Veterinary Vaccine Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 6.02%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Veterinary Vaccine Market Scope
Vaccines employed for the prevention of several diseases that affect animals can be grouped under veterinary vaccines. These vaccines are an important arrow in the quiver of the veterinarian and are arguably one of the most powerful tools in keeping animals healthy and well. They also have an impact on human health by ensuring safe food supplies and preventing animal-to-human transmission of infectious diseases. Also, these vaccines be an efficient tool in reducing the need to use antibiotics in animals, thereby contributing to the fight against antimicrobial resistance. Recent advances in technologies and improved understanding of pathogenicity, immunology, and epidemiology have opened new opportunities for preventing infectious diseases at an unprecedented level.

According to AMA, the Global Veterinary Vaccine market is expected to see growth rate of 6.02%

Research Analyst at AMA estimates that United States Vendors will contribute to the maximum growth of Global Veterinary Vaccine market throughout the predicted period.

Zoetis Animal Healthcare (United States), Merck & Co. (United States), Virbac SA (France), Hester Biosciences Ltd (India), Elanco (United States), Boehringer Ingelheim Animal Health GmbH (Germany), Ceva Sante Animale (France), Phibro Animal Health Corp. (United States), HIPRA (Spain) and MVP Laboratories Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research are QianYuanHao Biological Corporation Limited (China), IZO S.r.l. (Italy), Intervet International BV (Netherlands) and Indian Immunologicals Limited (India).

Segmentation Overview
The study have segmented the market of Global Veterinary Vaccine market by Type (Livestock Vaccines {Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Others} and Companion Animal Vaccines {Canine Vaccines, Feline Vaccines, Equine Vaccines}) and Region with country level break-up.

On the basis of geography, the market of Veterinary Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Growth Drivers:
Increasing Incidence of Livestock Diseases, Increasing Incidence of Zoonotic Diseases and Initiatives by Government Agencies and Animal Associations

Challenges:
Infectious & Bacterial Diseases Remain a Major Challenge

Restraints:
High Storage Costs for Vaccines and Shortage of Veterinarians and Skilled Farm Workers

Opportunities:
Recent Advancements in Technologies and Improved Understanding of Pathogenicity, Immunology and Epidemiology Have Opened New Opportunities

Market Leaders and their Expansionary Development Strategies
On 17 May 2019, Ceva Santé Animale (“Ceva”) and IDT Biologika GmbH have reached a provisional agreement for Ceva to acquire IDT’s veterinary biopharmaceutical portfolio and R&D activities, allowing IDT to focus on the manufacture of human biotechnology vaccines and pharmaceuticals for national and international markets. and On 26 April 2019, Elanco Animal Health has announced it has signed an agreement to acquire Aratana Therapeutics, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Galliprant. Elanco has also signed a development and commercialization agreement with VetDC for Tanovea-CA1, the first U.S. Food and Drug Administration (FDA) conditionally approved canine lymphoma treatment.
On 24 Jan. 2019, Boehringer Ingelheim, the world’s leading animal health company, announced that swine vaccine Ingelvac®PRRS MLV, produced by its veterinary vaccine manufacturing plant in the China Medical City in Taizhou, Jiangsu Province, is now officially supplied to the China market. Shifting imported vaccines to locally-produced vaccines will help significantly shorten the interval between the plant and animal farms. and On 12 Oct. 2018 – Boehringer Ingelheim has inaugurated its new global center for biological research and development at its Lyon Porte-des-Alpes (LPA) location in Saint-Priest France. With this 70 million euro investment, the German group signals its intention to reinforce its leading position in the veterinary vaccine market by bringing its R&D and biological production activities into the same center of excellence.
APHIS regulates veterinary biologics (vaccines, bacterins, antisera, diagnostic kits, and other products of biological origin) to ensure that the veterinary biologics available for the diagnosis, prevention, and treatment of animal diseases are pure, safe, potent, and effective. This work is done by APHIS Center for Veterinary Biologics (CVB) and is centered around enforcement of the Virus Serum Toxin Act.

Key Target Audience
Veterinary Vaccine Manufacturers, Veterinary Vaccine Raw Material Suppliers, Veterinary Vaccine Traders/Distributors, Veterinary Vaccine Importer/Exporter, Technology Investors, Government Research Institutes and Others

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Report Objectives / Segmentation Covered

By Type
  • Livestock Vaccines {Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Others}
  • Companion Animal Vaccines {Canine Vaccines, Feline Vaccines, Equine Vaccines}
By Technology
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Livestock Diseases
      • 3.2.2. Increasing Incidence of Zoonotic Diseases
      • 3.2.3. Initiatives by Government Agencies and Animal Associations
    • 3.3. Market Challenges
      • 3.3.1. Infectious & Bacterial Diseases Remain a Major Challenge
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Veterinary Vaccine, by Type, Technology and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Veterinary Vaccine (Value)
      • 5.2.1. Global Veterinary Vaccine by: Type (Value)
        • 5.2.1.1. Livestock Vaccines {Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Others}
        • 5.2.1.2. Companion Animal Vaccines {Canine Vaccines, Feline Vaccines, Equine Vaccines}
      • 5.2.2. Global Veterinary Vaccine by: Technology (Value)
        • 5.2.2.1. Live Attenuated Vaccines
        • 5.2.2.2. Inactivated Vaccines
        • 5.2.2.3. Toxoid Vaccines
        • 5.2.2.4. Recombinant Vaccines
        • 5.2.2.5. Others
      • 5.2.3. Global Veterinary Vaccine Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Veterinary Vaccine (Price)
      • 5.3.1. Global Veterinary Vaccine by: Type (Price)
  • 6. Veterinary Vaccine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis Animal Healthcare (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Virbac SA (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hester Biosciences Ltd (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Elanco (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boehringer Ingelheim Animal Health GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ceva Sante Animale (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Phibro Animal Health Corp. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. HIPRA (Spain)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. MVP Laboratories Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Veterinary Vaccine Sale, by Type, Technology and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Veterinary Vaccine (Value)
      • 7.2.1. Global Veterinary Vaccine by: Type (Value)
        • 7.2.1.1. Livestock Vaccines {Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Others}
        • 7.2.1.2. Companion Animal Vaccines {Canine Vaccines, Feline Vaccines, Equine Vaccines}
      • 7.2.2. Global Veterinary Vaccine by: Technology (Value)
        • 7.2.2.1. Live Attenuated Vaccines
        • 7.2.2.2. Inactivated Vaccines
        • 7.2.2.3. Toxoid Vaccines
        • 7.2.2.4. Recombinant Vaccines
        • 7.2.2.5. Others
      • 7.2.3. Global Veterinary Vaccine Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Veterinary Vaccine (Price)
      • 7.3.1. Global Veterinary Vaccine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Veterinary Vaccine: by Type(USD Million)
  • Table 2. Veterinary Vaccine Livestock Vaccines {Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Others} , by Region USD Million (2016-2021)
  • Table 3. Veterinary Vaccine Companion Animal Vaccines {Canine Vaccines, Feline Vaccines, Equine Vaccines} , by Region USD Million (2016-2021)
  • Table 4. Veterinary Vaccine: by Technology(USD Million)
  • Table 5. Veterinary Vaccine Live Attenuated Vaccines , by Region USD Million (2016-2021)
  • Table 6. Veterinary Vaccine Inactivated Vaccines , by Region USD Million (2016-2021)
  • Table 7. Veterinary Vaccine Toxoid Vaccines , by Region USD Million (2016-2021)
  • Table 8. Veterinary Vaccine Recombinant Vaccines , by Region USD Million (2016-2021)
  • Table 9. Veterinary Vaccine Others , by Region USD Million (2016-2021)
  • Table 10. South America Veterinary Vaccine, by Country USD Million (2016-2021)
  • Table 11. South America Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 12. South America Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 13. Brazil Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 14. Brazil Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 15. Argentina Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 16. Argentina Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 17. Rest of South America Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 18. Rest of South America Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 19. Asia Pacific Veterinary Vaccine, by Country USD Million (2016-2021)
  • Table 20. Asia Pacific Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 21. Asia Pacific Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 22. China Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 23. China Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 24. Japan Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 25. Japan Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 26. India Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 27. India Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 28. South Korea Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 29. South Korea Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 30. Taiwan Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 31. Taiwan Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 32. Australia Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 33. Australia Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 34. Rest of Asia-Pacific Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 35. Rest of Asia-Pacific Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 36. Europe Veterinary Vaccine, by Country USD Million (2016-2021)
  • Table 37. Europe Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 38. Europe Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 39. Germany Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 40. Germany Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 41. France Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 42. France Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 43. Italy Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 44. Italy Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 45. United Kingdom Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 46. United Kingdom Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 47. Netherlands Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 48. Netherlands Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 49. Rest of Europe Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 50. Rest of Europe Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 51. MEA Veterinary Vaccine, by Country USD Million (2016-2021)
  • Table 52. MEA Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 53. MEA Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 54. Middle East Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 55. Middle East Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 56. Africa Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 57. Africa Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 58. North America Veterinary Vaccine, by Country USD Million (2016-2021)
  • Table 59. North America Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 60. North America Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 61. United States Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 62. United States Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 63. Canada Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 64. Canada Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 65. Mexico Veterinary Vaccine, by Type USD Million (2016-2021)
  • Table 66. Mexico Veterinary Vaccine, by Technology USD Million (2016-2021)
  • Table 67. Veterinary Vaccine: by Type(USD/Units)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Veterinary Vaccine: by Type(USD Million)
  • Table 79. Veterinary Vaccine Livestock Vaccines {Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Others} , by Region USD Million (2022-2027)
  • Table 80. Veterinary Vaccine Companion Animal Vaccines {Canine Vaccines, Feline Vaccines, Equine Vaccines} , by Region USD Million (2022-2027)
  • Table 81. Veterinary Vaccine: by Technology(USD Million)
  • Table 82. Veterinary Vaccine Live Attenuated Vaccines , by Region USD Million (2022-2027)
  • Table 83. Veterinary Vaccine Inactivated Vaccines , by Region USD Million (2022-2027)
  • Table 84. Veterinary Vaccine Toxoid Vaccines , by Region USD Million (2022-2027)
  • Table 85. Veterinary Vaccine Recombinant Vaccines , by Region USD Million (2022-2027)
  • Table 86. Veterinary Vaccine Others , by Region USD Million (2022-2027)
  • Table 87. South America Veterinary Vaccine, by Country USD Million (2022-2027)
  • Table 88. South America Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 89. South America Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 90. Brazil Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 91. Brazil Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 92. Argentina Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 93. Argentina Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 94. Rest of South America Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 95. Rest of South America Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 96. Asia Pacific Veterinary Vaccine, by Country USD Million (2022-2027)
  • Table 97. Asia Pacific Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 98. Asia Pacific Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 99. China Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 100. China Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 101. Japan Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 102. Japan Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 103. India Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 104. India Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 105. South Korea Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 106. South Korea Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 107. Taiwan Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 108. Taiwan Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 109. Australia Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 110. Australia Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 111. Rest of Asia-Pacific Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 112. Rest of Asia-Pacific Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 113. Europe Veterinary Vaccine, by Country USD Million (2022-2027)
  • Table 114. Europe Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 115. Europe Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 116. Germany Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 117. Germany Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 118. France Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 119. France Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 120. Italy Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 121. Italy Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 122. United Kingdom Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 123. United Kingdom Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 124. Netherlands Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 125. Netherlands Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 126. Rest of Europe Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 127. Rest of Europe Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 128. MEA Veterinary Vaccine, by Country USD Million (2022-2027)
  • Table 129. MEA Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 130. MEA Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 131. Middle East Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 132. Middle East Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 133. Africa Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 134. Africa Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 135. North America Veterinary Vaccine, by Country USD Million (2022-2027)
  • Table 136. North America Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 137. North America Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 138. United States Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 139. United States Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 140. Canada Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 141. Canada Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 142. Mexico Veterinary Vaccine, by Type USD Million (2022-2027)
  • Table 143. Mexico Veterinary Vaccine, by Technology USD Million (2022-2027)
  • Table 144. Veterinary Vaccine: by Type(USD/Units)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Veterinary Vaccine: by Type USD Million (2016-2021)
  • Figure 5. Global Veterinary Vaccine: by Technology USD Million (2016-2021)
  • Figure 6. South America Veterinary Vaccine Share (%), by Country
  • Figure 7. Asia Pacific Veterinary Vaccine Share (%), by Country
  • Figure 8. Europe Veterinary Vaccine Share (%), by Country
  • Figure 9. MEA Veterinary Vaccine Share (%), by Country
  • Figure 10. North America Veterinary Vaccine Share (%), by Country
  • Figure 11. Global Veterinary Vaccine: by Type USD/Units (2016-2021)
  • Figure 12. Global Veterinary Vaccine share by Players 2021 (%)
  • Figure 13. Global Veterinary Vaccine share by Players (Top 3) 2021(%)
  • Figure 14. Global Veterinary Vaccine share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Zoetis Animal Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 17. Zoetis Animal Healthcare (United States) Revenue: by Geography 2021
  • Figure 18. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Merck & Co. (United States) Revenue: by Geography 2021
  • Figure 20. Virbac SA (France) Revenue, Net Income and Gross profit
  • Figure 21. Virbac SA (France) Revenue: by Geography 2021
  • Figure 22. Hester Biosciences Ltd (India) Revenue, Net Income and Gross profit
  • Figure 23. Hester Biosciences Ltd (India) Revenue: by Geography 2021
  • Figure 24. Elanco (United States) Revenue, Net Income and Gross profit
  • Figure 25. Elanco (United States) Revenue: by Geography 2021
  • Figure 26. Boehringer Ingelheim Animal Health GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 27. Boehringer Ingelheim Animal Health GmbH (Germany) Revenue: by Geography 2021
  • Figure 28. Ceva Sante Animale (France) Revenue, Net Income and Gross profit
  • Figure 29. Ceva Sante Animale (France) Revenue: by Geography 2021
  • Figure 30. Phibro Animal Health Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Phibro Animal Health Corp. (United States) Revenue: by Geography 2021
  • Figure 32. HIPRA (Spain) Revenue, Net Income and Gross profit
  • Figure 33. HIPRA (Spain) Revenue: by Geography 2021
  • Figure 34. MVP Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. MVP Laboratories Inc. (United States) Revenue: by Geography 2021
  • Figure 36. Global Veterinary Vaccine: by Type USD Million (2022-2027)
  • Figure 37. Global Veterinary Vaccine: by Technology USD Million (2022-2027)
  • Figure 38. South America Veterinary Vaccine Share (%), by Country
  • Figure 39. Asia Pacific Veterinary Vaccine Share (%), by Country
  • Figure 40. Europe Veterinary Vaccine Share (%), by Country
  • Figure 41. MEA Veterinary Vaccine Share (%), by Country
  • Figure 42. North America Veterinary Vaccine Share (%), by Country
  • Figure 43. Global Veterinary Vaccine: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Zoetis Animal Healthcare (United States)
  • Merck & Co. (United States)
  • Virbac SA (France)
  • Hester Biosciences Ltd (India)
  • Elanco (United States)
  • Boehringer Ingelheim Animal Health GmbH (Germany)
  • Ceva Sante Animale (France)
  • Phibro Animal Health Corp. (United States)
  • HIPRA (Spain)
  • MVP Laboratories Inc. (United States)
Additional players considered in the study are as follows:
QianYuanHao Biological Corporation Limited (China) , IZO S.r.l. (Italy) , Intervet International BV (Netherlands) , Indian Immunologicals Limited (India)
Select User Access Type

Key Highlights of Report


Jan 2024 225 Pages 76 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Veterinary Vaccine Quantitative research analysis
Global Veterinary Vaccine Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Veterinary Vaccine study can be customized to meet your requirements. The market size breakdown by type, by end-use application.
The Veterinary Vaccine Market is gaining popularity and expected to see strong valuation by 2027 and may reach USD 20820.0 Million .
According to AMA, the Global Veterinary Vaccine market is expected to see growth rate of xx%.
The Veterinary Vaccine market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Veterinary Vaccine Report?

Have a Query? Click Here

Other Related Reports

Precision Livestock Farming Comprehensive Study by Type (Precision Feeding Systems, Precision Milking Robots {Single-Stall Unit, Multi stall Unit}, Stable and FMS), Application (Swine, Ruminant, Poul...
$ 3750
Poultry Feed Premix Comprehensive Study by Application (Chicken, Duck, Goose, Others), Raw Material (Rice, Corn, Millets, Wheat, Others), Component (Minerals, Antibiotics, Vitamins, Amino Acids, Othe...
$ 3500
Layer Breeding Equipments Comprehensive Study by Type (Automation Equipment, Brooding Equipment, Cooling Equipment, Disinfection Equipment, Drinkers, Feeder, Heating Equipment, Others), Animal Breed ...
$ 3650
Shellfish Comprehensive Study by Type (Prawns, Crab, Clams, Whelk, Oysters, Others), Distribution Channels (Supermarket, Restaurant) Players and Region - Global Market Outlook to 2026
$ 3500
Monofilament Fishing Line Comprehensive Study by Type (Below 0.20 mm, 0.20-0.40 mm, 0.40-0.80 mm, Above 0.80 mm), Application (Freshwater Fishing, Saltwater Fishing), Distribution Channel (Online, Of...
$ 3350
Pork Meat Comprehensive Study by Type (Fresh Pork Meat Market, Processed Pork Meat Market), Distribution Channels (Supermarkets and Hypermarkets, Convenience Stores, Individual Retailers, Online Sale...
$ 3650